Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
NeoGenomics
MedTech
NeoGenomics moves forward with $390M option to buy out Inivata
The deal is expected to close in June, at which time Inivata’s business will become a separate liquid biopsy division under the NeoGenomics umbrella.
Andrea Park
May 6, 2021 12:27pm
NeoGenomics to acquire Genoptix in near $140M deal
Oct 26, 2018 10:35am
PPD, NeoGenomics to integrate lab testing for cancer trials
Jun 1, 2018 11:28am
